Watch the video below for Dr. Jack Regan’s recent interview with BioPub.

Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022
Home » Veterinary Diagnostics » Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022
LexaGene
LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.
Upcoming Events
Connexity® The Annual Conference of the American Animal Hospital Association
NashvilleSeptember 14, 2022 - September 17, 2022
LexaGene will be exhibiting AAHA's Connexity Event in September.